Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1999 3
2000 1
2001 2
2003 1
2004 1
2006 1
2007 2
2008 3
2009 1
2010 2
2011 1
2012 3
2013 2
2014 1
2015 2
2016 3
2017 3
2018 1
2019 2
2021 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; CLEAR Trial Investigators. Motzer R, et al. N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13. N Engl J Med. 2021. PMID: 33616314 Clinical Trial.
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.
Motzer RJ, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Alekseev B, Rha SY, Merchan J, Goh JC, Lalani AA, De Giorgi U, Melichar B, Hong SH, Gurney H, Méndez-Vidal MJ, Kopyltsov E, Tjulandin S, Gordoa TA, Kozlov V, Alyasova A, Winquist E, Maroto P, Kim M, Peer A, Procopio G, Takagi T, Wong S, Bedke J, Schmidinger M, Rodriguez-Lopez K, Burgents J, He C, Okpara CE, McKenzie J, Choueiri TK; CLEAR Trial Investigators. Motzer RJ, et al. J Clin Oncol. 2024 Apr 10;42(11):1222-1228. doi: 10.1200/JCO.23.01569. Epub 2024 Jan 16. J Clin Oncol. 2024. PMID: 38227898 Free article. Clinical Trial.
Colorectal cancer and Blastocystis sp. infection.
Sulżyc-Bielicka V, Kołodziejczyk L, Adamska M, Skotarczak B, Jaczewska S, Safranow K, Bielicki P, Kładny J, Bielicki D. Sulżyc-Bielicka V, et al. Parasit Vectors. 2021 Apr 14;14(1):200. doi: 10.1186/s13071-021-04681-x. Parasit Vectors. 2021. PMID: 33853659 Free PMC article.
Colorectal cancer and Cryptosporidium spp. infection.
Sulżyc-Bielicka V, Kołodziejczyk L, Jaczewska S, Bielicki D, Safranow K, Bielicki P, Kładny J, Rogowski W. Sulżyc-Bielicka V, et al. PLoS One. 2018 Apr 19;13(4):e0195834. doi: 10.1371/journal.pone.0195834. eCollection 2018. PLoS One. 2018. PMID: 29672572 Free PMC article.
Expression of cyclooxygenase-2 in colonic polyps.
Wasilewicz MP, Kołodziej B, Bojułko T, Kaczmarczyk M, Sulzyc-Bielicka V, Bielicki D. Wasilewicz MP, et al. Among authors: sulzyc bielicka v. Pol Arch Med Wewn. 2010 Sep;120(9):313-20. Pol Arch Med Wewn. 2010. PMID: 20864903 Free article.
Cryptosporidiosis in patients with colorectal cancer.
Sulzyc-Bielicka V, Kuźna-Grygiel W, Kołodziejczyk L, Bielicki D, Kładny J, Stepień-Korzonek M, Telatyńska-Smieszek B. Sulzyc-Bielicka V, et al. J Parasitol. 2007 Jun;93(3):722-4. doi: 10.1645/GE-1025R1.1. J Parasitol. 2007. PMID: 17626376
Association of COMT gene variability with pain intensity in patients after total hip replacement.
Machoy-Mokrzyńska A, Starzyńska-Sadura Z, Dziedziejko V, Safranow K, Kurzawski M, Leźnicka K, Sulżyc-Bielicka V, Jurewicz A, Bohatyrewicz A, Białecka M. Machoy-Mokrzyńska A, et al. Among authors: sulzyc bielicka v. Scand J Clin Lab Invest. 2019 May;79(3):202-207. doi: 10.1080/00365513.2019.1576920. Epub 2019 Mar 1. Scand J Clin Lab Invest. 2019. PMID: 30822160
37 results